All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Roche Holding AG, fresh off its $44 billion offer for Genentech Inc., moved to accelerate its research into RNAi gene silencing technology with the acquisition of Mirus Bio Corp. for $125 million. (BioWorld Today)
